BRCA1 and breast carcinoma: In one study of 105 BRCA1/2 germline pathogenic variant carriers diagnosed with breast cancer between 2005 and 2016, chemotherapy receipt was 59% overall, yet in the 42 patients with pre-diagnostic awareness of their BRCA status, 86% were diagnosed with stage 0-I disease and only 29% received chemotherapy [11].